PRRX1 and hypophosphatasia: Inhibition of calcium channel internalization by ionomycin increased calcium influx and enhanced bone formation in alpl+/− mice and Prrx1-alpl−/− mice, suggesting that targeting calcium channel internalization is a potential treatment strategy for adult patients with HPP.